Trial Profile
A phase I study of Cannabidiol/tetrahydrocannabinol (MedChew-1503) for the treatment of Dementia
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 11 Nov 2016
Price :
$35
*
At a glance
- Drugs Nabiximols (Primary)
- Indications Dementia
- Focus Adverse reactions; Therapeutic Use
- 11 Nov 2016 The profile has been written from Axim Biotech product pipeline. (http://aximbiotech.com/product-timeline/)
- 11 Nov 2016 New trial record